Subscribe To
Fda grants fast track designation for ambrx’s arx517 for the treatment of metastatic castration-resistant prostate cancer
SAN DIEGO, July 19, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that the U.S. Food an...
July 19, 2023, 1:03 pm
Sanofi (sny), astrazeneca's rsv antibody gets fda nod in infants
Following FDA approval, Sanofi (SNY)/AstraZeneca's (AZN) Beyfortus is the first RSV antibody approved t...
July 18, 2023, 12:50 pm
Eli lilly & co study shows alzheimer's drug slows memory decline
Eli Lilly & Co revealed on Monday final results from its Phase 3 clinical study of donanemab at the Alzheimer's Association International Conference i...
July 17, 2023, 1:13 pm
Us fda approves sanofi-astrazeneca's preventive rsv therapy for babies
U.S. Food and Drug Administration said on Monday it had approved Sanofi and partner AstraZeneca's antibody...
July 17, 2023, 1:07 pm
Exclusive: moonlake immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics , a developer of an antibody-derived treatment for inflammatory skin condit...
July 14, 2023, 3:38 pm
Eli lilly to acquire versanis bio, expanding obesity-treatment pipeline
Eli Lilly and Co. LLY, -1.34% will acquire Versanis Bio, a private clinical-stage biopharma company focused on new treatments for cardiometabolic dise...
July 14, 2023, 8:14 am
Eisai to present the latest alzheimer's disease pipeline and research, including lecanemab and anti-mtbr tau antibody e2814, at the alzheimer's association international conference (aaic) 2023
TOKYO , July 11, 2023 /PRNewswire/ -- Eisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will present the...
July 11, 2023, 7:30 pm
Biogen and alzheimer's disease: too early to celebrate
The FDA has granted full approval to Biogen and Eisai's anti-amyloid antibody drug Leqembi, but there i...
July 9, 2023, 11:52 pm
Aslan pharmaceuticals shares slide amid new data on atopic dermatitis treatment
Shares of Aslan Pharmaceuticals ASLN were down 32% premarket on Thursday after the company released new data from a clinical study of eblasakimab, an ...
July 6, 2023, 8:22 am
Evotec wins orthopoxvirus antibody contract from u.s. government
Evotec's Seattle-based subsidiary has won a $74 million contract with the U.S. Department of Defence to develop monoclonal ...
July 5, 2023, 1:59 am
Immunogen stock continues to defy gravity on phase 2 trials
ImmunoGen Inc. NASDAQ: IMGN is a commercial-stage biotechnology company leading in antibody-drug conjug...
June 26, 2023, 8:13 am
Aeglea (agle) soars 329% on acquiring spyre therapeutics
Aeglea's (AGLE) shares surge as it acquires Spyre Therapeutics, a private company that focuses on developing a...
June 23, 2023, 11:54 am
Roivant sciences shares gain after ulcerative colitis treatment shows longer-term results
Shares of Roivant Sciences Ltd. ROIV, -2.66% gained 14% in premarket trading Thursday after the company released new long-duration data from a study o...
June 22, 2023, 8:09 am
Roivant to host investor call at 8:00 am et on thursday, june 22 to review results from the chronic period of tuscany-2, a large global phase 2b study of rvt-3101 (anti-tl1a antibody) in ulcerative co
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 21, 2023 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq: ROIV) today announced that it will...
June 21, 2023, 9:00 pm
Mersana therapeutics announces partial clinical hold on up-next and upgrade-a clinical trials
UPLIFT top-line data expected by early August CAMBRIDGE, Mass., June 15, 2023 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinic...
June 15, 2023, 11:30 am
Ibio forges research collaboration with the national institutes of health
– NIH to evaluate iBio’s patented AI-driven epitope steering platform for Lassa fever vaccine development – BRYAN, Texas and SAN DIEGO, June 12,...
June 12, 2023, 8:15 pm
Cancervax reports positive progress on kids cancer immunotherapy treatment
UCLA research team has successfully created 7 pre-clinical monoclonal antibody candidates for targeting...
June 12, 2023, 4:27 pm
Biogen (biib), eisai alzheimer drug gets fda panel endorsement
An FDA advisory committee supports granting full approval to Biogen (BIIB)/Eisai's Alzheimer's disease antibod...
June 12, 2023, 10:28 am
Pyxis oncology: a high-stakes gambit in the battle against solid tumors
Pyxis Oncology is developing next-generation therapeutics, including antibody-drug conjugates and immun...
June 12, 2023, 2:59 am
Fda panel endorses astrazeneca (azn), sanofi's rsv antibody
The FDA's AMDAC unanimously recommends AstraZeneca (AZN)/Sanofi's (SNY) nirsevimab as full immunization against RSV disease for all infants....
June 9, 2023, 2:58 pm